ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for IDYA

Stock NameIdeaya Biosciences Inc
TickerIDYA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45166A1025
LEI549300ULW08F62IJML11

Show aggregate IDYA holdings

News associated with IDYA

IDEAYA Biosciences (NASDAQ:IDYA) Shares Up 5.6% After Analyst Upgrade
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report)’s stock price was up 5.6% on Tuesday after Royal Bank Of Canada raised their price target on the stock from $36.00 to $38.00. Royal Bank Of Canada currently has an outperform rating on the stock. IDEAYA Biosciences traded as high as $24.68 and last traded at $24.70. […] - 2025-09-11 02:13:34
IDEAYA Biosciences Announces Positive Interim Data From Ongoing Phase 2 Trial Of Darovasertib
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), Monday announced positive interim data from its ongoing Phase 2 OptimUM-09 trial of darovasertib in the neoadjuvant setting for primary uveal melanoma. - 2025-09-08 08:32:22
JPMorgan Chase & Co. Boosts IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $74.00
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its target price increased by stock analysts at JPMorgan Chase & Co. from $72.00 to $74.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 186.49% from […] - 2025-09-05 05:35:08
IDEAYA Biosciences (NASDAQ:IDYA) Trading Up 5.1% After Analyst Upgrade
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) traded up 5.1% on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $72.00 to $74.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. IDEAYA Biosciences traded as high as $26.31 and last traded at $26.78. […] - 2025-09-05 02:15:52
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $47.10 Average PT from Analysts
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve research firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average […] - 2025-09-02 03:06:51
Sum Up The Parts: ESML Could Be Worth $50
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-12 08:44:07
XTX Topco Ltd Acquires 17,536 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
XTX Topco Ltd grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 138.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 30,215 shares of the company’s stock after purchasing an additional 17,536 shares during the quarter. XTX Topco Ltd’s holdings in […] - 2025-08-08 04:40:50
TD Asset Management Inc Trims Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
TD Asset Management Inc decreased its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 46.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,036 shares of the company’s stock after selling 30,254 shares during the period. TD Asset Management […] - 2025-08-05 04:37:20
JPMorgan Chase & Co. Issues Positive Forecast for IDEAYA Biosciences (NASDAQ:IDYA) Stock Price
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its price target increased by analysts at JPMorgan Chase & Co. from $66.00 to $72.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 189.86% […] - 2025-07-30 03:06:51
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of “Moderate Buy” by Brokerages
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen analysts that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has given a strong buy recommendation to […] - 2025-07-11 05:22:55
LABU's Holdings Imply 58% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-10 07:59:01
Oppenheimer Asset Management Inc. Has $189,000 Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Oppenheimer Asset Management Inc. boosted its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 33.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,560 shares of the company’s stock after buying an additional 2,884 shares during the […] - 2025-07-01 04:51:00
Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) PT at $54.27
Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) have received an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy […] - 2025-06-19 02:14:54
Rhumbline Advisers Increases Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Rhumbline Advisers raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 9.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,437 shares of the company’s stock after acquiring an additional 10,876 shares during the period. Rhumbline Advisers’ […] - 2025-06-17 04:29:02
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 1.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 323,286 shares of the company’s stock after purchasing an additional 4,790 shares during the quarter. UBS AM a […] - 2025-06-01 05:37:01
Legal & General Group Plc Buys 6,064 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Legal & General Group Plc boosted its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,442 shares of the company’s stock after buying an additional 6,064 […] - 2025-04-25 05:12:49
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $53.58 Consensus Target Price from Brokerages
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the […] - 2025-04-23 02:32:56
JPMorgan Chase & Co. Acquires 194,913 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
JPMorgan Chase & Co. boosted its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 244.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 274,693 shares of the company’s stock after purchasing an additional 194,913 shares during the period. JPMorgan Chase & Co.’s holdings in IDEAYA Biosciences were worth […] - 2025-04-17 04:27:21
Geode Capital Management LLC Has $51.12 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Geode Capital Management LLC increased its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,988,681 shares of the company’s stock after purchasing an additional 43,226 shares during the […] - 2025-04-14 05:43:01
Wellington Management Group LLP Sells 2,321 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Wellington Management Group LLP cut its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 5.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 39,790 shares of the company’s stock after selling 2,321 shares during the quarter. Wellington Management Group LLP’s […] - 2025-04-14 04:50:48
Norges Bank Purchases Shares of 520,810 IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Norges Bank acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 520,810 shares of the company’s stock, valued at approximately $13,385,000. Several other institutional investors and hedge funds have also added to or reduced their stakes in IDYA. UBS AM a […] - 2025-04-08 06:22:52
Orion Portfolio Solutions LLC Reduces Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Orion Portfolio Solutions LLC reduced its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 39.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 17,769 shares of the company’s stock after selling 11,784 shares during the period. Orion Portfolio Solutions LLC’s holdings in IDEAYA Biosciences were worth $457,000 at the end of the […] - 2025-04-08 05:02:50
Vanguard Group Inc. Buys 282,936 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Vanguard Group Inc. increased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 5.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 5,078,084 shares of the company’s stock after purchasing an additional 282,936 shares during the quarter. Vanguard Group Inc. owned about 0.06% of IDEAYA Biosciences worth $130,507,000 […] - 2025-04-08 04:28:47
Mitsubishi UFJ Asset Management Co. Ltd. Sells 30,870 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Mitsubishi UFJ Asset Management Co. Ltd. trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 81.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,856 shares of the company’s stock after selling 30,870 […] - 2025-04-04 05:19:12
Charles Schwab Investment Management Inc. Acquires 23,738 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Charles Schwab Investment Management Inc. grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 712,811 shares of the company’s stock after purchasing an additional 23,738 shares during the period. Charles Schwab Investment […] - 2025-03-20 06:14:48
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 44.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,792 shares of the company’s stock after acquiring an additional 853 shares during the quarter. Daiwa Securities Group […] - 2025-03-18 05:43:16
AlphaQuest LLC Lowers Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
AlphaQuest LLC trimmed its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 77.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 7,661 shares of the company’s stock after selling 26,401 shares during the period. AlphaQuest LLC’s holdings in IDEAYA Biosciences were worth $197,000 at the end of the most recent […] - 2025-03-17 06:03:03
Victory Capital Management Inc. Buys 27,806 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Victory Capital Management Inc. increased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 8.9% in the 4th quarter, Holdings Channel reports. The firm owned 341,063 shares of the company’s stock after purchasing an additional 27,806 shares during the period. Victory Capital Management Inc.’s holdings in IDEAYA Biosciences were worth $8,765,000 as of […] - 2025-03-14 05:56:54
Assetmark Inc. Boosts Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Assetmark Inc. lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 2.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 45,269 shares of the company’s stock after purchasing an additional 1,084 shares during the period. Assetmark Inc. owned about 0.05% of IDEAYA Biosciences worth […] - 2025-03-12 05:58:56
Oppenheimer Asset Management Inc. Trims Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Oppenheimer Asset Management Inc. trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 28.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,676 shares of the company’s stock after selling 3,382 shares during the quarter. […] - 2025-03-07 06:45:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc IDYA holdings

DateNumber of IDYA Shares HeldBase Market Value of IDYA SharesLocal Market Value of IDYA SharesChange in IDYA Shares HeldChange in IDYA Base ValueCurrent Price per IDYA Share HeldPrevious Price per IDYA Share Held
2025-12-24 (Wednesday)21,349USD 761,732IDYA holding increased by 5764USD 761,7320USD 5,764 USD 35.68 USD 35.41
2025-12-23 (Tuesday)21,349IDYA holding decreased by -75USD 755,968IDYA holding decreased by -4584USD 755,968-75USD -4,584 USD 35.41 USD 35.5
2025-12-22 (Monday)21,424USD 760,552IDYA holding increased by 41777USD 760,5520USD 41,777 USD 35.5 USD 33.55
2025-12-19 (Friday)21,424USD 718,775IDYA holding increased by 6213USD 718,7750USD 6,213 USD 33.55 USD 33.26
2025-12-18 (Thursday)21,424USD 712,562IDYA holding decreased by -10070USD 712,5620USD -10,070 USD 33.26 USD 33.73
2025-12-17 (Wednesday)21,424USD 722,632IDYA holding decreased by -1713USD 722,6320USD -1,713 USD 33.73 USD 33.81
2025-12-16 (Tuesday)21,424USD 724,345IDYA holding increased by 9426USD 724,3450USD 9,426 USD 33.81 USD 33.37
2025-12-15 (Monday)21,424USD 714,919IDYA holding decreased by -13925USD 714,9190USD -13,925 USD 33.37 USD 34.02
2025-12-12 (Friday)21,424USD 728,844IDYA holding increased by 9855USD 728,8440USD 9,855 USD 34.02 USD 33.56
2025-12-11 (Thursday)21,424USD 718,989IDYA holding decreased by -1714USD 718,9890USD -1,714 USD 33.56 USD 33.64
2025-12-10 (Wednesday)21,424USD 720,703IDYA holding decreased by -9427USD 720,7030USD -9,427 USD 33.64 USD 34.08
2025-12-09 (Tuesday)21,424USD 730,130IDYA holding decreased by -26994USD 730,1300USD -26,994 USD 34.08 USD 35.34
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IDYA by Blackrock for IE00B3VWM098

Show aggregate share trades of IDYA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-23SELL-7536.00035.130 35.217USD -2,641 24.42 Loss of -810 on sale
2025-12-03SELL-37534.74033.143 33.303USD -12,489 23.76 Loss of -3,577 on sale
2025-12-02BUY15034.72033.420 33.550USD 5,032 23.72
2025-11-25SELL-22536.00034.500 34.650USD -7,796 23.43 Loss of -2,524 on sale
2025-11-24SELL-22535.12034.310 34.391USD -7,738 23.38 Loss of -2,478 on sale
2025-11-17SELL-82534.61031.700 31.991USD -26,393 23.13 Loss of -7,314 on sale
2025-11-12SELL-7532.69031.430 31.556USD -2,367 22.99 Loss of -642 on sale
2025-11-06SELL-7530.04029.080 29.176USD -2,188 22.83 Loss of -476 on sale
2025-11-05SELL-75030.84528.993 29.178USD -21,883 22.79 Loss of -4,787 on sale
2025-11-04SELL-15031.30029.770 29.923USD -4,488 22.75 Loss of -1,075 on sale
2025-11-03SELL-15032.02030.565 30.711USD -4,607 22.71 Loss of -1,200 on sale
2025-10-28BUY22533.19033.640 33.595USD 7,559 22.50
2025-10-24SELL-7529.18029.515 29.481USD -2,211 22.41 Loss of -530 on sale
2025-10-15BUY45028.38029.180 29.100USD 13,095 22.16
2025-10-02BUY7527.20027.830 27.767USD 2,083 22.10
2025-09-30BUY15027.21028.010 27.930USD 4,190 22.04
2025-09-11BUY30024.93025.360 25.317USD 7,595 21.93
2025-08-21SELL-8824.63024.680 24.675USD -2,171 21.91 Loss of -243 on sale
2025-07-31BUY26424.35025.690 25.556USD 6,747 21.88
2025-06-30SELL-17621.02021.630 21.569USD -3,796 21.81 Profit of 42 on sale
2025-06-25SELL-8822.01022.090 22.082USD -1,943 21.81 Loss of -24 on sale
2025-06-20SELL-17621.67022.005 21.971USD -3,867 21.81 Loss of -28 on sale
2025-05-23BUY8818.82018.900 18.892USD 1,662 21.93
2025-05-19SELL-8818.08018.110 18.107USD -1,593 22.03 Profit of 346 on sale
2025-05-15SELL-26417.31017.400 17.391USD -4,591 22.11 Profit of 1,246 on sale
2025-05-12SELL-8818.35018.760 18.719USD -1,647 22.23 Profit of 309 on sale
2025-05-09SELL-8917.42018.771 18.636USD -1,659 22.28 Profit of 324 on sale
2025-04-30SELL-8920.13020.510 20.472USD -1,822 22.47 Profit of 178 on sale
2025-04-24SELL-17819.07019.080 19.079USD -3,396 22.60 Profit of 626 on sale
2025-04-17SELL-8917.08017.130 17.125USD -1,524 22.84 Profit of 509 on sale
2025-04-15SELL-26716.98017.220 17.196USD -4,591 22.98 Profit of 1,544 on sale
2025-04-14SELL-26717.11017.300 17.281USD -4,614 23.04 Profit of 1,539 on sale
2025-04-09SELL-35615.78017.250 17.103USD -6,089 23.28 Profit of 2,200 on sale
2025-04-07SELL-62315.14015.390 15.365USD -9,572 23.48 Profit of 5,055 on sale
2025-04-04SELL-89014.71015.610 15.520USD -13,813 23.58 Profit of 7,175 on sale
2025-03-31BUY8916.38017.000 16.938USD 1,507 23.86
2025-03-19SELL-17818.21018.690 18.642USD -3,318 24.50 Profit of 1,044 on sale
2025-03-14SELL-53418.58019.450 19.363USD -10,340 24.75 Profit of 2,876 on sale
2025-03-13SELL-17818.96019.590 19.527USD -3,476 24.83 Profit of 944 on sale
2025-03-12SELL-3,02618.60019.090 19.041USD -57,618 24.92 Profit of 17,796 on sale
2025-03-07SELL-17818.46019.670 19.549USD -3,480 25.23 Profit of 1,011 on sale
2025-03-06SELL-26719.07019.635 19.579USD -5,227 25.32 Profit of 1,534 on sale
2025-03-03SELL-8919.13021.090 20.894USD -1,860 25.62 Profit of 421 on sale
2025-02-28SELL-39,78820.57020.590 20.588USD -819,155 25.71 Profit of 203,696 on sale
2025-02-26SELL-19320.75021.370 21.308USD -4,112 25.88 Profit of 883 on sale
2025-02-25SELL-57920.85021.510 21.444USD -12,416 25.97 Profit of 2,621 on sale
2025-02-18BUY96520.44021.654 21.533USD 20,779 26.42
2025-02-13BUY19320.76021.860 21.750USD 4,198 26.75
2025-02-12BUY19321.95021.960 21.959USD 4,238 26.85
2025-02-11BUY57921.38022.270 22.181USD 12,843 26.96
2025-02-06BUY1,73723.96025.250 25.121USD 43,635 27.22
2025-01-27BUY19323.80024.730 24.637USD 4,755 27.90
2024-12-30BUY96524.93025.080 25.065USD 24,188 28.34
2024-12-06BUY77227.79028.000 27.979USD 21,600 28.40
2024-12-05BUY19326.37028.560 28.341USD 5,470 28.47
2024-12-04BUY96028.35028.650 28.620USD 27,475 28.47
2024-11-29BUY96027.36027.590 27.567USD 26,464 28.63
2024-11-27BUY76826.99027.120 27.107USD 20,818 28.77
2024-11-26BUY19226.78027.370 27.311USD 5,244 28.86
2024-11-21BUY96026.60026.880 26.852USD 25,778 29.21
2024-11-20BUY57625.54026.050 25.999USD 14,975 29.41
2024-11-18BUY2,30426.19027.080 26.991USD 62,187 29.84
2024-11-12BUY1,53630.98032.000 31.898USD 48,995 29.76
2024-11-08BUY96031.28031.490 31.469USD 30,210 29.65
2024-11-07BUY2,88029.99030.620 30.557USD 88,004 29.63
2024-11-06BUY38430.41031.730 31.598USD 12,134 29.56
2024-10-31BUY19228.15029.260 29.149USD 5,597 29.80
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IDYA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19159,347700337,97247.1%
2025-09-18102,0620354,53828.8%
2025-09-17129,2330282,40545.8%
2025-09-16140,7820365,50738.5%
2025-09-15180,7190331,98554.4%
2025-09-12251,06097384,31465.3%
2025-09-11257,9370806,17932.0%
2025-09-10399,0930657,59560.7%
2025-09-09540,94347,4281,130,11047.9%
2025-09-08663,53840,3401,460,24545.4%
2025-09-05291,425501857,89634.0%
2025-09-04293,83411,632650,37045.2%
2025-09-03206,4140498,51341.4%
2025-09-02399,30201,106,95136.1%
2025-08-29138,3810240,02657.7%
2025-08-2887,7670231,89537.8%
2025-08-2776,9520183,70641.9%
2025-08-2671,7660218,28732.9%
2025-08-25220,7610315,81869.9%
2025-08-22106,324525349,11130.5%
2025-08-21183,6780348,67452.7%
2025-08-20304,7580418,62572.8%
2025-08-19249,3400466,09553.5%
2025-08-18292,9466,166430,25868.1%
2025-08-15128,2370249,93951.3%
2025-08-14133,6742,000225,12659.4%
2025-08-13135,3580258,28952.4%
2025-08-1295,6360234,47540.8%
2025-08-11185,9410306,49160.7%
2025-08-08164,5312,628237,90569.2%
2025-08-07138,6120221,91462.5%
2025-08-06154,817268246,54462.8%
2025-08-05376,4344488,35877.1%
2025-08-04195,0990399,20448.9%
2025-08-01200,9680273,78073.4%
2025-07-31147,5003,884285,25451.7%
2025-07-30324,1780777,67141.7%
2025-07-29255,786529370,79669.0%
2025-07-28365,8850971,51537.7%
2025-07-25201,606556370,99354.3%
2025-07-24467,727391,117,56541.9%
2025-07-23265,550258381,03369.7%
2025-07-22139,9040500,68127.9%
2025-07-2195,9280244,88439.2%
2025-07-1885,2550126,80567.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy